If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Joint Development Agreement

5 Mar 2010 07:00

RNS Number : 1175I
Quadrise Fuels International PLC
05 March 2010
 



Quadrise Fuels International plc ("QFI" or "the Company")

 

Agreement with A.P. Moller-Maersk for MSAR® Marine Bunker Fuel

 

5 March 2010

 

Quadrise Fuels International plc ("QFI" or "the Company"), the producer of oil-in-water emulsion fuel as a low cost substitute for heavy fuel oil for use in power plants and industrial diesel engines, advises that it has signed a Joint Development Agreement with A.P. Moller - Maersk ("Maersk") to jointly investigate and develop over an approximate 12 month period a marine version of its MSAR® emulsion fuel. Maersk are the world's largest container shipping organisation and the largest single purchaser of bunker fuel.

 

The development programme will capitalise on QFI's skills in emulsion fuel application and use in large diesel engines. Maersk will contribute their vast shipping industry experience and provide unsurpassed technical expertise relating to naval architecture, machinery systems, fuels, exhaust gas emissions and technical ship management. Maersk vessels provide excellent testing platforms for new technologies.

 

In the event the development programme is successful Maersk and QFI will seek to expediently implement the technology.

 

Commenting on the development Bill Howe, Chief Executive Officer of QFI said:

 

"This co-operative development is a very exciting opportunity for QFI. The diesel engine application of MSAR® represents a market sector with limited inter-fuels competition. Bunker fuel, driven by expansion in international trade, is a long-term growth market and comprises 150 million tons per annum, approximately 30% of the global heavy fuel oil market. Bunker fuel represents a high proportion of shipping industry operating costs and there is great potential for MSAR® if the technology can be successfully adapted to the marine application".

 

QFI will announce its interim results for the half year ended 31st December 2009 on 29th March 2010.

 

Enquiries:

 

Quadrise Fuels International plc Tel: +44 (0)772 537 2841

Bill Howe, Chief Executive Officer

 

Fairfax I.S. PLC Tel: +44 (0)207 598 4073

Katy Birkin

 

Capital MS&L Tel: +44 (0)207 307 5330

Penny Freer

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRMMGGFVDDGGZM
Date   Source Headline
2nd Feb 20217:00 amRNSUpdate re Morocco and Greenfield Energy Projects
1st Feb 20217:00 amRNSUpdate re bioMSAR Testing at Aquafuel Research Ltd
27th Jan 20217:00 amRNSIssue of Equity
21st Jan 20217:00 amRNSJoint Development Agreement - MSC Shipmanagement
6th Jan 20217:00 amRNSIssue of Equity
4th Jan 20217:00 amRNSChange of Registered Office
18th Dec 202011:46 amRNSUpdate re Greenfield MSAR Trial
18th Dec 20207:00 amRNSbioMSAR Testing Update & Collaboration Agreement
15th Dec 20207:00 amRNSLaunch of bioMSAR
3rd Dec 20207:00 amRNSPublication of Americas White Paper
27th Nov 202012:13 pmRNSResult of AGM
27th Nov 20207:00 amRNSAGM Statement
24th Nov 20208:00 amEQSQuadrise Fuels International (QFI): The clean solution to a global problem
2nd Nov 20205:23 pmRNSPosting of Annual Report and Notice of AGM
26th Oct 20207:00 amRNSMorocco Update
5th Oct 20207:00 amRNSFinal Results, Investor Presentation & AGM Notice
7th Sep 20205:56 pmRNSIssue of Equity
7th Sep 20207:00 amRNSNotice of Results, Update and Investor Event
24th Aug 20207:00 amRNSIssue of Share Options
20th Aug 20207:00 amRNSIssue of Equity
18th Aug 20207:22 amRNSGreenfield MSAR Commercial Trial Agreement
17th Aug 20207:00 amRNSPublication of White Paper
17th Jul 20203:59 pmRNSInvestor Presentation
30th Jun 20209:18 amRNSHolding(s) in Company
24th Jun 20204:41 pmRNSSecond Price Monitoring Extn
24th Jun 20204:37 pmRNSPrice Monitoring Extension
23rd Jun 20207:00 amRNSIssue of Equity
18th Jun 20207:00 amRNSStatement re MSAR Licensing and Upstream Trial
17th Jun 20201:47 pmRNSStatement re MSAR Licensing
2nd Jun 20207:00 amRNSInvestor Presentation
1st May 20207:00 amRNSFurther Statement re Covid-19 and Update
16th Apr 20202:21 pmRNSIssue of Equity
15th Apr 20207:00 amRNSDirectorate Change
30th Mar 20204:13 pmRNSNew Website
30th Mar 202011:02 amRNSHalf-year Report - Replacement
30th Mar 20207:00 amRNSHalf-year Report
24th Mar 202010:13 amRNSIssue of Equity
16th Mar 20207:00 amRNSStatement re Covid-19 and Morocco Pilot Trial
5th Mar 20209:10 amRNSUpdate on Morocco Pilot Trial
17th Feb 20207:00 amRNSNotice of Interim Results and Business Update
30th Jan 20207:00 amRNSAppointment of New Auditors
15th Jan 20207:00 amRNSDirectorate Changes
16th Dec 20198:38 amRNSDirectorate Change
29th Nov 20194:42 pmRNSResult of AGM
29th Nov 20197:05 amRNSIssue of Warrants
29th Nov 20197:00 amRNSMaterial Transfer & Cooperation Agreement
29th Nov 20197:00 amRNSAGM Update
6th Nov 20195:03 pmRNSPosting of Annual Report and Notice of AGM
10th Oct 20195:42 pmRNSHolding(s) in Company
8th Oct 20197:00 amRNSNew three-year Exclusive Agreement with Nouryon

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.